Cigna

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cigna and other ETFs, options, and stocks.

About CI

The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. 

CEO
David Michael Cordani
CEODavid Michael Cordani
Employees
72,500
Employees72,500
Headquarters
Bloomfield, Connecticut
HeadquartersBloomfield, Connecticut
Founded
1792
Founded1792
Employees
72,500
Employees72,500

CI Key Statistics

Market cap
97.68B
Market cap97.68B
Price-Earnings ratio
20.53
Price-Earnings ratio20.53
Dividend yield
1.43%
Dividend yield1.43%
Average volume
1.41M
Average volume1.41M
High today
$361.15
High today$361.15
Low today
$342.30
Low today$342.30
Open price
$358.63
Open price$358.63
Volume
2.81M
Volume2.81M
52 Week high
$365.71
52 Week high$365.71
52 Week low
$240.50
52 Week low$240.50

CI News

TipRanks 18h
CI Earnings: Cigna Rises on Strong Q1 Performance

Cigna Group (NYSE:CI) shares rose by nearly 3% in the early trading session today after the insurance and health services major delivered robust first-quarter r...

Seeking Alpha 3d
Alvotech to produce Humira biosimilar for Cigna's Quallent

Alvotech (NASDAQ:ALVO) has confirmed it will manufacture a high-concentration biosimilar of AbbVie’s (ABBV) blockbuster drug Humira for Cigna’s (CI) Quallent Ph...

Alvotech to produce Humira biosimilar for Cigna's Quallent
Investor's Business Daily 3d
This Managed Care Leader Sets Up A New Buy Point Heading Into Earnings

Stock patterns may not appear to offer any clues for investors at first glance. However, a more careful reading can reveal scaffolds for investors to step as co...

This Managed Care Leader Sets Up A New Buy Point Heading Into Earnings

Analyst ratings

79%

of 24 ratings
Buy
79.2%
Hold
20.8%
Sell
0%

More CI News

TipRanks 6d
AbbVie Sinks as Humira Drug Sees Increased Competition - TipRanks.com - TipRanks

Shares of AbbVie (NYSE:ABBV) sank on Friday after the pharmaceutical company reported first-quarter results. Despite beating earnings estimates ($2.31 per share...

Seeking Alpha 6d
AbbVie stock slides 6% amid concerns about falling Humira sales

Shares of AbbVie (NYSE:ABBV) were down 6% in afternoon trading Friday in the wake of the drugmaker's Q1 earnings report and news that Cigna (CI) plans to offer...

AbbVie stock slides 6% amid concerns about falling Humira sales
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.